Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances

2023/05/25 by Giovanni Musso, Francesca Saba, Maurizio Cassader +1 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Endoplasmic Reticulum Stress and Disease #Lipid metabolism and biosynthesis #Liver Disease Diagnosis and Treatment

paper · doi:10.1016/j.plipres.2023.101238

openalex publication_date 2023/05/25 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/15

Citations

• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
• Metabolic engineering of microorganisms to produce omega-3 very long-chain polyunsaturated fatty acids
• Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing
• Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
• Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation
• Molecular mechanisms for biosynthesis and assembly of nutritionally important very long chain polyunsaturated fatty acids in microorganisms
• Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
• PARPs in lipid metabolism and related diseases
• Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

Cited by

• Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication